首页 | 本学科首页   官方微博 | 高级检索  
     

参附注射液联合美托洛尔治疗冠心病心力衰竭的临床研究
引用本文:杨钦,林雪莲. 参附注射液联合美托洛尔治疗冠心病心力衰竭的临床研究[J]. 黑龙江医学, 2011, 35(2): 114-115. DOI: 10.3969/j.issn.1004-5775.2011.02.013
作者姓名:杨钦  林雪莲
作者单位:1. 广东省电白县林头中心卫生院内科,广东,电白,525424
2. 广东省电白县人民医院内科,广东,电白,525400
摘    要:目的 观察参附注射液联合美托洛尔治疗冠心病并心力衰竭的临床疗效和安全性.方法 选择冠心病心力衰竭患者64例,随机分为对照组和联合组各32例.对照组常规给予强心甙、利尿剂、血管扩张剂和血管紧张素转换酶抑制剂,心绞痛时加用硝酸酯类药物等西药治疗.联合组在西药常规治疗基础上,应用参附注射液50 mL加入5%葡萄糖100 mL...

关 键 词:参附注射液  美托洛尔  冠心病  心力衰竭  心功能

Clinical Study on Treatment of Coronary Heart Failure with Shengfu Injection and Metoprolol
YANG Qin,LIN Xue-lian. Clinical Study on Treatment of Coronary Heart Failure with Shengfu Injection and Metoprolol[J]. Heilongjiang Medical Journal, 2011, 35(2): 114-115. DOI: 10.3969/j.issn.1004-5775.2011.02.013
Authors:YANG Qin  LIN Xue-lian
Affiliation:(Department of Internal Medicine,the Lintou Center Hospital of Dianbai County,Guangdong Province,Dianbai 525424,CHINA)
Abstract:Objective observe the curative effect and safety of treatment of CHF with shenfu injection and metoprolol.Methods 64 cases of such patient were divided into two groups randomly.The test group was treated with shenfu injection of 50 mL qd.and metoprolol of 12.5~ 25 mg bid.for twice weeks as a course on the bases of control group. Results The total effective rate was 87.5% that was higher than that of control group of 65.5% with P <0.05.The LVDd and LVEF were better in test group than those in control group with P <0.05. Conclusion This combination method might improve the LHF and clinical symptom and life quality that should be used in clinic.
Keywords:Shenfu injection  Metoprolol  CHD  HF  Heart function
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号